Connect to Protect Partnerships for Youth Prevention Interventions: Phase II

NCT00103896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16706

Last updated 2017-03-01

No results posted yet for this study

Summary

This is Phase II of a three stage project whose overall goals are to develop viable community-based HIV prevention interventions and to form and maintain the necessary community collaborations to support such Adolescent Trials Network (ATN) research activities.

This phase will describe specific locations within high-risk areas where youth, ages 12-24, spend time. HIV risk behaviors, social networking patterns and HIV prevalence among youth at these venues will be assessed by administering anonymous computerized interviews to eligible and willing youth. This information will be shared with community partners during scheduled working group meetings.

Conditions

  • HIV Infection

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Jonathan Ellen, MD · Johns Hopkins Medical Center

  • Ligia Peralta, MD · Division of Adolescent & Young Adult Medicine University of MD, Medical School

  • Donna Futterman, MD · Montefiore Medical Center

  • Marvin Belzer, MD · Childrens Hosp of Los Angeles, Division of Adolescent Medicine

  • Bret Rudy, MD · Children's Hospital of Philadelphia

  • Larry D'Angelo, MD · Children's National Research Institute

  • Cathryn Samples, MD · Boston Children's Hospital

  • Lisa Henry-Reid, MD · John H. Stroger Jr. Hospital and the CORE Center

  • Ana Puga, MD · Children's Diag. and Treatment Ctr of Ft. Lauderdale, FL

  • Lawrence Friedman, MD · University of Miami, School of Medicine, Div of Adolescent Medicine

  • Patricia Emmanuel, MD · University of South Florida, Peds Div of Infectious Disease

  • Sue Ellen Abdalian, MD · Tulane Medical Center

  • Linda Levin, MD · Mount Sinai Adolescent Health Center

  • Irma Febo, MD · University of Puerto Rico Medical Sciences Campus

  • Stephen A Spector, MD · UCSD Mother, Child, & Adolescent HIV Program

  • Rolando M Viani, MD · UCSD Mother, Child, & Adolescent HIV Program

  • Barbara Moscicki, MD · UCSF, Division of Adoles. Med

  • Coco Auerswald, MD · UCSF, Division of Adoles. Med

Eligibility

Min Age
12 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00103896 on ClinicalTrials.gov